6-ethylchenodeoxycholic acid ( DrugBank: 6-ethylchenodeoxycholic acid )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
93原発性胆汁性胆管炎11

93. 原発性胆汁性胆管炎


臨床試験数 : 298 薬物数 : 252 - (DrugBank : 59) / 標的遺伝子数 : 35 - 標的パスウェイ数 : 115
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2007-001424-12-DE
(EUCTR)
22/04/200923/10/2008A Study of INT-747 (6-ECDCA) Monotherapy in Patientswith Primary Biliary Cirrhosis A Study of INT-747 (6-ECDCA) Monotherapy in Patientswith Primary Biliary Cirrhosis Primary biliary cirrhosis
MedDRA version: 9.1;Level: PT;Classification code 10004661;Term: Biliary cirrhosis primary
Product Name: INT-747
Product Code: INT-747
INN or Proposed INN: Obeticholic acid
Other descriptive name: 6a-ethylchenodeoxycholic acid, 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5ßcholan-24-o
Product Name: INT-747
Product Code: INT-747
INN or Proposed INN: Obeticholic acid
Other descriptive name: 6a-ethylchenodeoxycholic acid , 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5ßcholan-24-o
Product Name: INT-747
Product Code: INT-747
INN or Proposed INN: Obeticholic acid
Other descriptive name: 6a-ethylchenodeoxycholic acid , 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5ßcholan-24-o
Intercept PharmaceuticalsNULLNot RecruitingFemale: yes
Male: yes
120Phase 2France;Spain;Austria;Germany;United Kingdom
2EUCTR2007-001424-12-GB
(EUCTR)
21/04/200903/09/2007 A Study of INT 747 Monotherapy in Patients with Primary Biliary Cirrhosis A Study of INT-747 (6-ECDCA) Monotherapy in Patients with Primary Biliary Cirrhosis Primary biliary cirrhosis
MedDRA version: 18.0;Level: PT;Classification code 10004661;Term: Biliary cirrhosis primary;System Organ Class: 10019805 - Hepatobiliary disorders ;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
Product Name: INT-747
Product Code: INT-747
INN or Proposed INN: Obeticholic acid
Other descriptive name: 6a-ethylchenodeoxycholic acid, 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5ßcholan-24-o , obeticholic acid (OCA)
Product Name: INT-747
Product Code: INT-747
INN or Proposed INN: Obeticholic acid
Other descriptive name: 6a-ethylchenodeoxycholic acid , 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5ßcholan-24-o, obeticholic acid (OCA)
Product Name: INT-747
Product Code: INT-747
INN or Proposed INN: Obeticholic acid
Other descriptive name: 6a-ethylchenodeoxycholic acid , 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5ßcholan-24-o, obeticholic acid (OCA)
Intercept PharmaceuticalsNULLNot Recruiting Female: yes
Male: yes
120 Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): yes Therapeutic confirmatory - (Phase 3): no Therapeutic use (Phase 4): noFrance;Spain;Austria;Germany;United Kingdom
3EUCTR2007-001424-12-AT
(EUCTR)
13/03/200909/09/2008A Study of INT-747 (6-ECDCA) Monotherapy in Patientswith Primary Biliary Cirrhosis A Study of INT-747 (6-ECDCA) Monotherapy in Patientswith Primary Biliary Cirrhosis Primary biliary cirrhosis
MedDRA version: 9.1;Level: PT;Classification code 10004661;Term: Biliary cirrhosis primary
Product Name: INT-747
Product Code: INT-747
INN or Proposed INN: 3a,7a-dihydroxy-6a-ethyl-5ßcholan-24-oic acid
Other descriptive name: 6a-ethylchenodeoxycholic acid, 6-ethylchenodeoxycholic acid
Product Name: INT-747
Product Code: INT-747
INN or Proposed INN: 3a,7a-dihydroxy-6a-ethyl-5ßcholan-24-oic acid
Other descriptive name: 6a-ethylchenodeoxycholic acid , 6-ethylchenodeoxycholic acid
Intercept PharmaceuticalsNULLNot RecruitingFemale: yes
Male: yes
120Phase 2France;Spain;Austria;Germany;United Kingdom
4EUCTR2007-001425-10-AT
(EUCTR)
13/03/200927/08/2008A Study of INT-747 (6-ECDCA) in Combination with Ursodeoxycholic Acid (URSO®, UDCA) in Patients with Primary Biliary CirrhosisA Study of INT-747 (6-ECDCA) in Combination with Ursodeoxycholic Acid (URSO®, UDCA) in Patients with Primary Biliary Cirrhosis Primary biliary cirrhosis
MedDRA version: 9.1;Level: PT;Classification code 10004661;Term: Biliary cirrhosis primary
Product Name: INT-747
Product Code: INT-747
INN or Proposed INN: Obeticholic acid
Other descriptive name: 6a-ethylchenodeoxycholic acid, 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5ßcholan-24-o
Product Name: INT-747
Product Code: INT-747
INN or Proposed INN: Obeticholic acid
Other descriptive name: 6a-ethylchenodeoxycholic acid , 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5ßcholan-24-o
Product Name: INT-747
Product Code: INT-747
INN or Proposed INN: Obeticholic acid
Other descriptive name: 6a-ethylchenodeoxycholic acid , 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5ßcholan-24-o
Intercept PharmaceuticalsNULLNot RecruitingFemale: yes
Male: yes
140Germany;United Kingdom;Netherlands;France;Spain;Austria
5EUCTR2007-001425-10-NL
(EUCTR)
11/02/200903/09/2008A Study of INT-747 (6-ECDCA) in Combination with Ursodeoxycholic Acid (URSO®, UDCA) in Patients with Primary Biliary CirrhosisA Study of INT-747 (6-ECDCA) in Combination with Ursodeoxycholic Acid (URSO®, UDCA) in Patients with Primary Biliary Cirrhosis Primary biliary cirrhosis
MedDRA version: 9.1;Level: PT;Classification code 10004661;Term: Biliary cirrhosis primary
Product Name: INT-747
Product Code: INT-747
INN or Proposed INN: 3a,7a-dihydroxy-6a-ethyl-5ßcholan-24-oic acid
Other descriptive name: 6a-ethylchenodeoxycholic acid, 6-ethylchenodeoxycholic acid
Product Name: INT-747
Product Code: INT-747
INN or Proposed INN: 3a,7a-dihydroxy-6a-ethyl-5ßcholan-24-oic acid
Other descriptive name: 6a-ethylchenodeoxycholic acid , 6-ethylchenodeoxycholic acid
Product Name: INT-747
Product Code: INT-747
INN or Proposed INN: 3a,7a-dihydroxy-6a-ethyl-5ßcholan-24-oic acid
Other descriptive name: 6a-ethylchenodeoxycholic acid , 6-ethylchenodeoxycholic acid
Intercept PharmaceuticalsNULLNot RecruitingFemale: yes
Male: yes
140Germany;United Kingdom;Netherlands;France;Spain;Austria
6EUCTR2007-001425-10-DE
(EUCTR)
27/01/200924/10/2008A Study of INT-747 (6-ECDCA) in Combination with Ursodeoxycholic Acid (URSO®, UDCA) in Patients with Primary Biliary CirrhosisA Study of INT-747 (6-ECDCA) in Combination with Ursodeoxycholic Acid (URSO®, UDCA) in Patients with Primary Biliary Cirrhosis Primary biliary cirrhosis
MedDRA version: 9.1;Level: PT;Classification code 10004661;Term: Biliary cirrhosis primary
Product Name: INT-747
Product Code: INT-747
INN or Proposed INN: Obeticholic acid
Other descriptive name: 6a-ethylchenodeoxycholic acid, 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5ßcholan-24-o
Product Name: INT-747
Product Code: INT-747
INN or Proposed INN: Obeticholic acid
Other descriptive name: 6a-ethylchenodeoxycholic acid , 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5ßcholan-24-o
Product Name: INT-747
Product Code: INT-747
INN or Proposed INN: Obeticholic acid
Other descriptive name: 6a-ethylchenodeoxycholic acid , 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5ßcholan-24-o
Intercept PharmaceuticalsNULLNot RecruitingFemale: yes
Male: yes
140United Kingdom;Germany;Netherlands;France;Spain;Austria
7EUCTR2007-001425-10-GB
(EUCTR)
13/10/200827/06/2008A Study of INT-747 (6-ECDCA) in Combination with Ursodeoxycholic Acid (URSO®, UDCA) in Patients with Primary Biliary CirrhosisA Study of INT-747 (6-ECDCA) in Combination with Ursodeoxycholic Acid (URSO®, UDCA) in Patients with Primary Biliary Cirrhosis Primary biliary cirrhosis
MedDRA version: 9.1;Level: PT;Classification code 10004661;Term: Biliary cirrhosis primary
Product Name: INT-747
Product Code: INT-747
INN or Proposed INN: Obeticholic acid
Other descriptive name: 6a-ethylchenodeoxycholic acid, 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5ßcholan-24-o
Product Name: INT-747
Product Code: INT-747
INN or Proposed INN: Obeticholic acid
Other descriptive name: 6a-ethylchenodeoxycholic acid , 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5ßcholan-24-o
Product Name: INT-747
Product Code: INT-747
INN or Proposed INN: Obeticholic acid
Other descriptive name: 6a-ethylchenodeoxycholic acid , 6-ethylchenodeoxycholic acid, 3a,7a-dihydroxy-6a-ethyl-5ßcholan-24-o
Intercept PharmaceuticalsNULLNot RecruitingFemale: yes
Male: yes
140Germany;United Kingdom;Netherlands;France;Spain;Austria
8EUCTR2007-001425-10-FR
(EUCTR)
26/09/200806/08/2008A Study of INT-747 (6-ECDCA) in Combination with Ursodeoxycholic Acid (URSO®, UDCA) in Patients with Primary Biliary CirrhosisA Study of INT-747 (6-ECDCA) in Combination with Ursodeoxycholic Acid (URSO®, UDCA) in Patients with Primary Biliary Cirrhosis Primary biliary cirrhosis
MedDRA version: 9.1;Level: PT;Classification code 10004661;Term: Biliary cirrhosis primary
Product Name: INT-747
Product Code: INT-747
INN or Proposed INN: 3a,7a-dihydroxy-6a-ethyl-5ßcholan-24-oic acid
Other descriptive name: 6a-ethylchenodeoxycholic acid, 6-ethylchenodeoxycholic acid
Product Name: INT-747
Product Code: INT-747
INN or Proposed INN: 3a,7a-dihydroxy-6a-ethyl-5ßcholan-24-oic acid
Other descriptive name: 6a-ethylchenodeoxycholic acid , 6-ethylchenodeoxycholic acid
Product Name: INT-747
Product Code: INT-747
INN or Proposed INN: 3a,7a-dihydroxy-6a-ethyl-5ßcholan-24-oic acid
Other descriptive name: 6a-ethylchenodeoxycholic acid , 6-ethylchenodeoxycholic acid
Intercept PharmaceuticalsNULLNot RecruitingFemale: yes
Male: yes
140Phase 2France;Spain;Austria;Germany;Netherlands;United Kingdom
9EUCTR2007-001425-10-ES
(EUCTR)
24/09/200823/07/2008Estudio del INT-747 (6-ECDCA) en combinación con el ácido ursodesoxicólico (URSO®, UDCA) en pacientes con cirrosis biliar primariaA Study of INT-747 (6-ECDCA) in Combination with Ursodeoxycholic Acid (URSO®, UDCA) in Patients with Primary Biliary CirrhosisEstudio del INT-747 (6-ECDCA) en combinación con el ácido ursodesoxicólico (URSO®, UDCA) en pacientes con cirrosis biliar primariaA Study of INT-747 (6-ECDCA) in Combination with Ursodeoxycholic Acid (URSO®, UDCA) in Patients with Primary Biliary Cirrhosis cirrosis biliar primaria
MedDRA version: 9.1;Level: PT;Classification code 10004661;Term: Biliary cirrhosis primary
Product Name: INT-747
Product Code: INT-747
INN or Proposed INN: 3a,7a-dihydroxy-6a-ethyl-5ßcholan-24-oic acid
Other descriptive name: 6a-ethylchenodeoxycholic acid, 6-ethylchenodeoxycholic acid
Product Name: INT-747
Product Code: INT-747
INN or Proposed INN: 3a,7a-dihydroxy-6a-ethyl-5ßcholan-24-oic acid
Other descriptive name: 6a-ethylchenodeoxycholic acid , 6-ethylchenodeoxycholic acid
Product Name: INT-747
Product Code: INT-747
INN or Proposed INN: 3a,7a-dihydroxy-6a-ethyl-5ßcholan-24-oic acid
Other descriptive name: 6a-ethylchenodeoxycholic acid , 6-ethylchenodeoxycholic acid
Intercept PharmaceuticalsNULLNot RecruitingFemale: yes
Male: yes
140Phase 2France;Spain;Austria;Germany;Netherlands;United Kingdom
10EUCTR2007-001424-12-FR
(EUCTR)
29/07/200816/05/2008A Study of INT-747 (6-ECDCA) Monotherapy in Patientswith Primary Biliary Cirrhosis A Study of INT-747 (6-ECDCA) Monotherapy in Patientswith Primary Biliary Cirrhosis Primary biliary cirrhosis
MedDRA version: 9.1;Level: PT;Classification code 10004661;Term: Biliary cirrhosis primary
Product Name: INT-747
Product Code: INT-747
INN or Proposed INN: 3a,7a-dihydroxy-6a-ethyl-5ßcholan-24-oic acid
Other descriptive name: 6a-ethylchenodeoxycholic acid, 6-ethylchenodeoxycholic acid
Product Name: INT-747
Product Code: INT-747
INN or Proposed INN: 3a,7a-dihydroxy-6a-ethyl-5ßcholan-24-oic acid
Other descriptive name: 6a-ethylchenodeoxycholic acid , 6-ethylchenodeoxycholic acid
Intercept PharmaceuticalsNULLNot RecruitingFemale: yes
Male: yes
120Phase 2France;Spain;Austria;Germany;United Kingdom
11EUCTR2007-001424-12-ES
(EUCTR)
15/07/200822/05/2008Estudio de la monoterapia INT-747 (6-ECDCA) en pacientes concirrosis biliar primariaA Study of INT-747 (6-ECDCA) Monotherapy in Patientswith Primary Biliary Cirrhosis Estudio de la monoterapia INT-747 (6-ECDCA) en pacientes concirrosis biliar primariaA Study of INT-747 (6-ECDCA) Monotherapy in Patientswith Primary Biliary Cirrhosis cirrosis biliar primaria
MedDRA version: 9.1;Level: PT;Classification code 10004661;Term: Biliary cirrhosis primary
Product Name: INT-747
Product Code: INT-747
INN or Proposed INN: 3a,7a-dihydroxy-6a-ethyl-5ßcholan-24-oic acid
Other descriptive name: 6a-ethylchenodeoxycholic acid, 6-ethylchenodeoxycholic acid
Product Name: INT-747
Product Code: INT-747
INN or Proposed INN: 3a,7a-dihydroxy-6a-ethyl-5ßcholan-24-oic acid
Other descriptive name: 6a-ethylchenodeoxycholic acid , 6-ethylchenodeoxycholic acid
Intercept PharmaceuticalsNULLNot RecruitingFemale: yes
Male: yes
120Phase 2France;Spain;Austria;Germany;United Kingdom